nodes	percent_of_prediction	percent_of_DWPC	metapath
Nadolol—ADRB2—autistic disorder	0.847	1	CbGaD
Nadolol—Pirbuterol—ADRB2—autistic disorder	0.0016	0.159	CrCbGaD
Nadolol—Levobunolol—ADRB2—autistic disorder	0.00143	0.142	CrCbGaD
Nadolol—Penbutolol—HTR1B—autistic disorder	0.00127	0.126	CrCbGaD
Nadolol—Carteolol—ADRB2—autistic disorder	0.00121	0.121	CrCbGaD
Nadolol—Bupranolol—ADRB2—autistic disorder	0.00103	0.103	CrCbGaD
Nadolol—Salbutamol—ADRB2—autistic disorder	0.000971	0.0965	CrCbGaD
Nadolol—Penbutolol—ADRB2—autistic disorder	0.000945	0.0939	CrCbGaD
Nadolol—Pindolol—HTR1B—autistic disorder	0.000915	0.091	CrCbGaD
Nadolol—Pindolol—ADRB2—autistic disorder	0.000681	0.0677	CrCbGaD
Nadolol—ADRB1—Signaling Pathways—GABBR2—autistic disorder	7.24e-05	0.000505	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—HTR2A—autistic disorder	7.19e-05	0.000502	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—PLA2G4A—autistic disorder	7.18e-05	0.000501	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—OXT—autistic disorder	7.13e-05	0.000497	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—HTR1B—autistic disorder	7.13e-05	0.000497	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GABBR2—autistic disorder	7.08e-05	0.000494	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—HTR2A—autistic disorder	7e-05	0.000489	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—GZMB—autistic disorder	6.78e-05	0.000473	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—DRD1—autistic disorder	6.77e-05	0.000473	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—SLC1A3—autistic disorder	6.77e-05	0.000472	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—AQP4—autistic disorder	6.77e-05	0.000472	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—DRD1—autistic disorder	6.63e-05	0.000462	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—OXT—autistic disorder	6.62e-05	0.000462	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—HTR1B—autistic disorder	6.62e-05	0.000462	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—HTR1B—autistic disorder	6.58e-05	0.00046	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—OXT—autistic disorder	6.58e-05	0.00046	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—DRD3—autistic disorder	6.56e-05	0.000458	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—TDO2—autistic disorder	6.49e-05	0.000453	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—HTR1B—autistic disorder	6.47e-05	0.000452	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—OXT—autistic disorder	6.47e-05	0.000452	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HTR1D—autistic disorder	6.45e-05	0.00045	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—IL5—autistic disorder	6.42e-05	0.000448	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—DRD3—autistic disorder	6.42e-05	0.000448	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—HTR2A—autistic disorder	6.36e-05	0.000444	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CALCA—autistic disorder	6.34e-05	0.000443	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HTR1D—autistic disorder	6.31e-05	0.00044	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—IL5—autistic disorder	6.28e-05	0.000438	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—APC—autistic disorder	6.25e-05	0.000436	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PRLR—autistic disorder	6.21e-05	0.000433	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CALCA—autistic disorder	6.2e-05	0.000433	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—autistic disorder	6.18e-05	0.000431	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—DRD1—autistic disorder	6.15e-05	0.000429	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—PRKCB—autistic disorder	6.14e-05	0.000428	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—DRD1—autistic disorder	6.12e-05	0.000427	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—TSC1—autistic disorder	6.12e-05	0.000427	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—DHCR7—autistic disorder	6.1e-05	0.000426	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PRLR—autistic disorder	6.07e-05	0.000424	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—CP—autistic disorder	6.03e-05	0.000421	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—DRD1—autistic disorder	6.02e-05	0.00042	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—GRM8—autistic disorder	6e-05	0.000419	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—DRD3—autistic disorder	5.96e-05	0.000416	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—NTRK2—autistic disorder	5.96e-05	0.000416	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—DRD3—autistic disorder	5.93e-05	0.000414	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—PIK3CG—autistic disorder	5.87e-05	0.00041	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—POMC—autistic disorder	5.87e-05	0.00041	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GRM8—autistic disorder	5.87e-05	0.000409	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—IL5—autistic disorder	5.83e-05	0.000407	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—DRD3—autistic disorder	5.83e-05	0.000407	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—WNT2—autistic disorder	5.81e-05	0.000405	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IL5—autistic disorder	5.8e-05	0.000405	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—EXT1—autistic disorder	5.79e-05	0.000404	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—SLC6A8—autistic disorder	5.79e-05	0.000404	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CALCA—autistic disorder	5.76e-05	0.000402	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—POMC—autistic disorder	5.74e-05	0.000401	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CALCA—autistic disorder	5.73e-05	0.0004	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—autistic disorder	5.72e-05	0.000399	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—GHR—autistic disorder	5.72e-05	0.000399	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—IL5—autistic disorder	5.7e-05	0.000398	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—WNT2—autistic disorder	5.68e-05	0.000396	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PDE4A—autistic disorder	5.64e-05	0.000393	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CALCA—autistic disorder	5.63e-05	0.000393	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GHR—autistic disorder	5.6e-05	0.000391	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—POMC—autistic disorder	5.59e-05	0.00039	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—PRKCB—autistic disorder	5.57e-05	0.000389	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—DAO—autistic disorder	5.52e-05	0.000385	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PDE4A—autistic disorder	5.52e-05	0.000385	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—PIK3CG—autistic disorder	5.33e-05	0.000372	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—ADRB2—autistic disorder	5.31e-05	0.000371	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—UPB1—autistic disorder	5.29e-05	0.000369	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—AVPR1A—autistic disorder	5.28e-05	0.000368	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—AVPR1A—autistic disorder	5.16e-05	0.00036	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—TF—autistic disorder	5.13e-05	0.000358	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—VIP—autistic disorder	5.1e-05	0.000356	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—GRM5—autistic disorder	5.1e-05	0.000356	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—POMC—autistic disorder	5.08e-05	0.000354	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—PRL—autistic disorder	5.06e-05	0.000353	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—autistic disorder	5e-05	0.000349	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—AVP—autistic disorder	4.99e-05	0.000348	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GRM5—autistic disorder	4.99e-05	0.000348	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—VIP—autistic disorder	4.99e-05	0.000348	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—OXTR—autistic disorder	4.94e-05	0.000345	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GSTM5—autistic disorder	4.92e-05	0.000343	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ASMT—autistic disorder	4.92e-05	0.000343	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—SCT—autistic disorder	4.89e-05	0.000341	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—AVP—autistic disorder	4.88e-05	0.000341	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—OXTR—autistic disorder	4.83e-05	0.000337	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—ADRB2—autistic disorder	4.83e-05	0.000337	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—ADRB2—autistic disorder	4.8e-05	0.000335	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—SCT—autistic disorder	4.78e-05	0.000334	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—autistic disorder	4.75e-05	0.000331	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—ADM—autistic disorder	4.66e-05	0.000325	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—GABBR1—autistic disorder	4.66e-05	0.000325	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—SLC25A12—autistic disorder	4.63e-05	0.000323	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—EIF4E—autistic disorder	4.58e-05	0.00032	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GABBR1—autistic disorder	4.56e-05	0.000318	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—ADM—autistic disorder	4.56e-05	0.000318	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PDE4B—autistic disorder	4.54e-05	0.000317	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—AVP—autistic disorder	4.53e-05	0.000316	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—AVP—autistic disorder	4.51e-05	0.000315	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—SLC19A1—autistic disorder	4.5e-05	0.000314	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IGF2—autistic disorder	4.49e-05	0.000314	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—EIF4E—autistic disorder	4.48e-05	0.000313	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PDE4B—autistic disorder	4.45e-05	0.00031	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—AVP—autistic disorder	4.44e-05	0.00031	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—OPRM1—autistic disorder	4.4e-05	0.000307	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—OPRM1—autistic disorder	4.31e-05	0.0003	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—PLA2G4A—autistic disorder	4.26e-05	0.000298	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—PLA2G4A—autistic disorder	4.24e-05	0.000296	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—PLA2G4A—autistic disorder	4.17e-05	0.000291	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—HTR2A—autistic disorder	4.15e-05	0.00029	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—autistic disorder	4.14e-05	0.000289	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—IL2—autistic disorder	4.13e-05	0.000288	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—MEF2C—autistic disorder	4.13e-05	0.000288	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—HTR2A—autistic disorder	4.06e-05	0.000284	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—GZMB—autistic disorder	4.03e-05	0.000281	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—ITGB3—autistic disorder	4.02e-05	0.000281	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ADSL—autistic disorder	4.01e-05	0.00028	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GZMB—autistic disorder	3.94e-05	0.000275	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—XDH—autistic disorder	3.93e-05	0.000274	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HTR1B—autistic disorder	3.91e-05	0.000273	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—OXT—autistic disorder	3.91e-05	0.000273	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—NPAS2—autistic disorder	3.86e-05	0.000269	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—STX1A—autistic disorder	3.86e-05	0.000269	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—OXT—autistic disorder	3.82e-05	0.000267	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HTR1B—autistic disorder	3.82e-05	0.000267	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—HTR2A—autistic disorder	3.77e-05	0.000263	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—HTR2A—autistic disorder	3.76e-05	0.000262	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—IL2—autistic disorder	3.75e-05	0.000262	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—TCN2—autistic disorder	3.73e-05	0.00026	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—HTR2A—autistic disorder	3.69e-05	0.000258	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—PRKCB—autistic disorder	3.64e-05	0.000254	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—TSC1—autistic disorder	3.63e-05	0.000254	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—DRD1—autistic disorder	3.63e-05	0.000254	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—TSC2—autistic disorder	3.57e-05	0.000249	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—PRKCB—autistic disorder	3.56e-05	0.000249	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ADA—autistic disorder	3.56e-05	0.000248	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—AVP—autistic disorder	3.56e-05	0.000248	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—DRD1—autistic disorder	3.55e-05	0.000248	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—TSC1—autistic disorder	3.55e-05	0.000248	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NTRK2—autistic disorder	3.53e-05	0.000247	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—DRD3—autistic disorder	3.52e-05	0.000246	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—LEP—autistic disorder	3.49e-05	0.000244	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—APOE—autistic disorder	3.49e-05	0.000244	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—PIK3CG—autistic disorder	3.49e-05	0.000243	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NTRK2—autistic disorder	3.46e-05	0.000241	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IL5—autistic disorder	3.44e-05	0.00024	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—DRD3—autistic disorder	3.44e-05	0.00024	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—PIK3CG—autistic disorder	3.41e-05	0.000238	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CALCA—autistic disorder	3.4e-05	0.000237	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IL5—autistic disorder	3.37e-05	0.000235	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—autistic disorder	3.37e-05	0.000235	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CALCA—autistic disorder	3.33e-05	0.000232	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—POMC—autistic disorder	3.32e-05	0.000232	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—PRKCB—autistic disorder	3.31e-05	0.000231	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—PRKCB—autistic disorder	3.29e-05	0.00023	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—POMC—autistic disorder	3.25e-05	0.000227	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—RORA—autistic disorder	3.24e-05	0.000226	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—PRKCB—autistic disorder	3.24e-05	0.000226	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—PIK3CG—autistic disorder	3.17e-05	0.000221	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—APC—autistic disorder	3.15e-05	0.00022	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—PIK3CG—autistic disorder	3.15e-05	0.00022	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—EGF—autistic disorder	3.11e-05	0.000217	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—PIK3CG—autistic disorder	3.1e-05	0.000216	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—MAOB—autistic disorder	3.04e-05	0.000212	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—POMC—autistic disorder	3.01e-05	0.00021	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PRL—autistic disorder	3.01e-05	0.00021	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—POMC—autistic disorder	3e-05	0.000209	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—POMC—autistic disorder	2.95e-05	0.000206	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PRL—autistic disorder	2.94e-05	0.000205	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IGF1—autistic disorder	2.88e-05	0.000201	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—MAPK1—autistic disorder	2.87e-05	0.0002	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—ADRB2—autistic disorder	2.85e-05	0.000199	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—TPH2—autistic disorder	2.83e-05	0.000197	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—DPYD—autistic disorder	2.78e-05	0.000194	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—SERPINE1—autistic disorder	2.74e-05	0.000191	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—AVP—autistic disorder	2.68e-05	0.000187	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IGF2—autistic disorder	2.67e-05	0.000186	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—AVP—autistic disorder	2.62e-05	0.000183	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IGF2—autistic disorder	2.61e-05	0.000182	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CACNA1C—autistic disorder	2.58e-05	0.00018	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PLA2G4A—autistic disorder	2.52e-05	0.000176	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PLA2G4A—autistic disorder	2.46e-05	0.000172	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—IL2—autistic disorder	2.45e-05	0.000171	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—MEF2C—autistic disorder	2.45e-05	0.000171	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—IL2—autistic disorder	2.4e-05	0.000167	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—MEF2C—autistic disorder	2.4e-05	0.000167	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—ITGB3—autistic disorder	2.39e-05	0.000167	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—DHFR—autistic disorder	2.35e-05	0.000164	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—ITGB3—autistic disorder	2.34e-05	0.000163	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—HRAS—autistic disorder	2.3e-05	0.000161	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HTR2A—autistic disorder	2.23e-05	0.000156	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—IL2—autistic disorder	2.23e-05	0.000155	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IL2—autistic disorder	2.22e-05	0.000155	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—IL6—autistic disorder	2.21e-05	0.000154	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HTR2A—autistic disorder	2.18e-05	0.000152	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—IL2—autistic disorder	2.18e-05	0.000152	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—TSC2—autistic disorder	2.12e-05	0.000148	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—PTEN—autistic disorder	2.09e-05	0.000146	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—LEP—autistic disorder	2.07e-05	0.000145	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—APOE—autistic disorder	2.07e-05	0.000145	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—TSC2—autistic disorder	2.07e-05	0.000145	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—LEP—autistic disorder	2.03e-05	0.000141	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—APOE—autistic disorder	2.03e-05	0.000141	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PRKCB—autistic disorder	1.95e-05	0.000136	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PRKCB—autistic disorder	1.91e-05	0.000133	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—APC—autistic disorder	1.87e-05	0.000131	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PIK3CG—autistic disorder	1.87e-05	0.000131	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—EGF—autistic disorder	1.85e-05	0.000129	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CYP19A1—autistic disorder	1.84e-05	0.000129	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PIK3CG—autistic disorder	1.83e-05	0.000128	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—APC—autistic disorder	1.83e-05	0.000128	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—EGF—autistic disorder	1.81e-05	0.000126	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—POMC—autistic disorder	1.78e-05	0.000124	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—POMC—autistic disorder	1.74e-05	0.000122	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IGF1—autistic disorder	1.71e-05	0.000119	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—COMT—autistic disorder	1.71e-05	0.000119	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—MAPK1—autistic disorder	1.7e-05	0.000119	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GSTP1—autistic disorder	1.7e-05	0.000119	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—MAOA—autistic disorder	1.7e-05	0.000119	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—MAPK1—autistic disorder	1.7e-05	0.000118	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IGF1—autistic disorder	1.67e-05	0.000117	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—MAPK1—autistic disorder	1.67e-05	0.000116	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CAT—autistic disorder	1.66e-05	0.000116	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—SERPINE1—autistic disorder	1.63e-05	0.000113	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—SERPINE1—autistic disorder	1.59e-05	0.000111	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GSTM1—autistic disorder	1.57e-05	0.000109	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PLA2G4A—autistic disorder	1.57e-05	0.000109	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GPX1—autistic disorder	1.5e-05	0.000105	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—MTHFR—autistic disorder	1.38e-05	9.66e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—HRAS—autistic disorder	1.37e-05	9.55e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—HRAS—autistic disorder	1.36e-05	9.5e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—HRAS—autistic disorder	1.34e-05	9.34e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IL2—autistic disorder	1.32e-05	9.18e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—IL6—autistic disorder	1.31e-05	9.14e-05	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IL6—autistic disorder	1.3e-05	9.09e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—APOE—autistic disorder	1.29e-05	8.99e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IL2—autistic disorder	1.29e-05	8.98e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—IL6—autistic disorder	1.28e-05	8.94e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PTEN—autistic disorder	1.24e-05	8.64e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PTEN—autistic disorder	1.21e-05	8.45e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PIK3CG—autistic disorder	1.16e-05	8.11e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—POMC—autistic disorder	1.11e-05	7.72e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—MAPK1—autistic disorder	1.01e-05	7.02e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—MAPK1—autistic disorder	9.85e-06	6.87e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PTGS2—autistic disorder	8.83e-06	6.16e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HRAS—autistic disorder	8.08e-06	5.64e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HRAS—autistic disorder	7.91e-06	5.52e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IL6—autistic disorder	7.74e-06	5.4e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PTEN—autistic disorder	7.7e-06	5.37e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IL6—autistic disorder	7.57e-06	5.28e-05	CbGpPWpGaD
